Is butorphanol analgesic in dogs and cats?

Veterinary Medicine

Volumn 94, Issue 4, 1999, Pages 346-350

  Wagner, Ann E ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007012952     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. 2-adrenoreceptor agonists in sheep. Animal Pain (C.E. Short; A. Van Poznak, eds.). Churchill Livingstone, New York, N.Y., 1992; pp 372-377.
2. Raffe, M.R.; Lipowitz, A.J.: Evaluation of butorphanol tartrate analgesia in the dog (abst.). Proc. 2nd Int. Cong. Vet. Anesth., International Congress of Veterinary Anesthesia, Sacramento, Calif., 1985; p 155.
3. Sawyer, D.C. et al: Dose response to butorphanol administered subcutaneously to increase visceral nociceptive threshold in dogs. AJVR 52:1826-1830; 1991.
4. Sawyer, D.C. et al. Does ketamine provide adequate visceral analgesia when used alone or in combination with acepromazine, diazepam, or butorphanol in cats? JAAHA 29:257-265; 1993.
5. Sawyer, D.C.; Rech, R.H.: Analgesia and behavioral effects of butorphanol, nalbuphine, and pentazocine in the cat. JAAHA 23:438-446; 1987.
6. Waterman, A.E.; Kalthum, W.: Use of opioids in providing postoperative analgesia in the dog: A double-blind trial of pethidine, pentazocine, buprenorphine, and butorphanol. Animal Pain (C.E. Short; A. Van Poznak, eds.). Churchill Livingstone, New York, N.Y., 1992; pp 466-476.
7. Murphy, M.R.; Hug, C.C.: The enflurane sparing effect of morphine, butorphanol, and nalbuphine. Anesthesiology 57:489-492; 1982.
8. Quandt, J.E. et al. Butorphanol does not reduce the minimum alveolar concentration of halothane in dogs. Vet. Anesth. 23:156-159; 1994.
9. Dyson, D.H. et al: Reversal of oxymorphone sedation by naloxone, nalmefene, and butorphanol. Vet. Surg. 19:398-403; 1990.
10. McCrackin, M.A. et al: Butorphanol tartrate for partial reversal of oxymorphone-induced postoperative respiratory depression in the dog. Vet. Surg. 23:67-74; 1994.
11. Lemke, K.A. et al: Ability of flumazenil, butorphanol, and naloxone to reverse the anesthetic effects of oxymorphone-diazepam in dogs. JAVMA 209:776-779; 1996.
12. Hansen, B.; Hardie, E.: Prescription and use of analgesics in dogs and cats in a veterinary teaching hospital: 258 cases (1983-1989). JAVMA 202:1485-1494; 1993.
13. Benson, G.J. et al: Assessment of analgesia by catecholamine analysis: Response to onychectomy in cats. Animal Pain (C.E. Short; A. Van Poznak, eds.). Churchill Livingstone, New York, N.Y., 1992; pp 436-439.
14. Carroll, G.L. et al. Evaluation of analgesia provided by postoperative administration of butorphanol to cats undergoing onychectomy. JAVMA 213:246-250; 1998.
15. Branson, K.R. et al: Opioid agonists and antagonists. Veterinary Pharmacology and Therapeutics, 7th Ed. (H.R. Adams, ed.). Iowa State University Press, Ames, 1995; pp 274-310.
16. Hansen, B.: Management of postoperative pain in dogs and cats. Predictable Pain Management. Pfizer Animal Health, Exton, Pa., 1996; pp 13-19.
17. Pascoe, P.J.: Control of postoperative pain in animals receiving inhalant anesthetics. Animal Pain (C.E. Short; A. Van Poznak, eds.). Churchill Livingstone, New York, N.Y., 1992; pp 348-352.